Suppr超能文献

[血管紧张素转换酶抑制剂的术前给药]

[Preoperative administration of angiotensin-converting enzyme inhibitors].

作者信息

Schirmer U, Schürmann W

机构信息

Abteilung Kardioanästhesiologie, Universitätsklinikum Ulm, Steinhövelstr. 9, 89075, Ulm.

出版信息

Anaesthesist. 2007 Jun;56(6):557-61. doi: 10.1007/s00101-007-1177-x.

Abstract

INTRODUCTION

The discussion about perioperative withdrawal or continuation of angiotensin-converting enzyme inhibitors (ACEI) remains controversial. Should it be continued to avoid peaks in blood pressure and heart rate during anesthesia? Or should it be discontinued the day before to avoid clinically relevant hypotonia? What is the greater risk? Since there are only a few studies dealing with this question, we compared the cardio-circulatory reaction during anesthesia after withdrawal and with continuation of ACEI therapy.

METHODS

A total of 100 hypertonic patients chronically treated with ACEIs were included in this prospective, randomized, double blind study. The last ACEI medication was given with the premedication in the morning (premed) or on the day before (withdrawal). Blood pressure and heart rate during induction and termination of anesthesia were compared between both groups. A threshold value for vasopressor therapy was determined to be a mean arterial pressure of 60 mmHg.

RESULTS

In the premed group Akrinor was necessary significantly more often and in higher dosages. Nevertheless, following induction the blood pressure and heart rates were significantly lower compared to the withdrawal group. The highest blood pressure and heart rate during induction and termination of anesthesia did not differ between the groups.

CONCLUSIONS

The continuation of ACEI therapy in the morning is not associated with a better control of blood pressure and heart rate but causes a more pronounced hypotension which forced a therapy more often. Patients chronically treated with ACEI should receive the ACEI the last time on the day before the operation and not with the premedication in the morning.

摘要

引言

关于围手术期停用或继续使用血管紧张素转换酶抑制剂(ACEI)的讨论仍存在争议。是应该继续使用以避免麻醉期间血压和心率峰值?还是应该在术前一天停药以避免出现临床相关的低血压?哪种风险更大?由于仅有少数研究涉及此问题,我们比较了停用ACEI治疗和继续使用ACEI治疗的患者在麻醉期间的心血管反应。

方法

本前瞻性、随机、双盲研究共纳入100例长期接受ACEI治疗的高血压患者。最后一剂ACEI药物在上午术前用药时给予(术前用药组)或在术前一天给予(停药组)。比较两组患者麻醉诱导期和结束时的血压和心率。将血管升压药治疗的阈值设定为平均动脉压60 mmHg。

结果

术前用药组使用阿克雷诺(Akrinor)的频率显著更高,剂量也更大。然而,与停药组相比,诱导后血压和心率显著更低。两组患者在麻醉诱导期和结束时的最高血压和心率无差异。

结论

上午继续使用ACEI治疗并不能更好地控制血压和心率,反而会导致更明显的低血压,从而更频繁地需要进行治疗。长期接受ACEI治疗的患者应在手术前一天最后一次服用ACEI,而不是在上午术前用药时服用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验